No abstract available
MeSH terms
-
Animals
-
Antioxidants / therapeutic use
-
Antiviral Agents / adverse effects
-
Antiviral Agents / therapeutic use*
-
Betacoronavirus / drug effects*
-
Betacoronavirus / immunology
-
Betacoronavirus / pathogenicity
-
COVID-19
-
COVID-19 Drug Treatment
-
Coronavirus Infections / drug therapy*
-
Coronavirus Infections / immunology
-
Coronavirus Infections / virology
-
Dietary Supplements* / adverse effects
-
Enzyme Inhibitors / therapeutic use
-
Host Microbial Interactions
-
Humans
-
Hydrogen Peroxide / metabolism
-
Immunologic Factors / therapeutic use
-
Influenza, Human / drug therapy*
-
Influenza, Human / immunology
-
Influenza, Human / virology
-
Interferon Type I / immunology
-
Interferon Type I / metabolism*
-
NADPH Oxidase 2 / antagonists & inhibitors
-
NADPH Oxidase 2 / metabolism
-
Orthomyxoviridae / drug effects*
-
Orthomyxoviridae / immunology
-
Orthomyxoviridae / pathogenicity
-
Pandemics
-
Pneumonia, Viral / drug therapy*
-
Pneumonia, Viral / immunology
-
Pneumonia, Viral / virology
-
SARS-CoV-2
-
Toll-Like Receptor 7 / metabolism
-
Virulence
Substances
-
Antioxidants
-
Antiviral Agents
-
Enzyme Inhibitors
-
Immunologic Factors
-
Interferon Type I
-
TLR7 protein, human
-
Toll-Like Receptor 7
-
Hydrogen Peroxide
-
CYBB protein, human
-
NADPH Oxidase 2